Correlation Between Nurix Therapeutics and Arvinas
Can any of the company-specific risk be diversified away by investing in both Nurix Therapeutics and Arvinas at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nurix Therapeutics and Arvinas into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nurix Therapeutics and Arvinas, you can compare the effects of market volatilities on Nurix Therapeutics and Arvinas and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nurix Therapeutics with a short position of Arvinas. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nurix Therapeutics and Arvinas.
Diversification Opportunities for Nurix Therapeutics and Arvinas
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Nurix and Arvinas is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Nurix Therapeutics and Arvinas in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arvinas and Nurix Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nurix Therapeutics are associated (or correlated) with Arvinas. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arvinas has no effect on the direction of Nurix Therapeutics i.e., Nurix Therapeutics and Arvinas go up and down completely randomly.
Pair Corralation between Nurix Therapeutics and Arvinas
Given the investment horizon of 90 days Nurix Therapeutics is expected to under-perform the Arvinas. But the stock apears to be less risky and, when comparing its historical volatility, Nurix Therapeutics is 1.06 times less risky than Arvinas. The stock trades about -0.18 of its potential returns per unit of risk. The Arvinas is currently generating about -0.08 of returns per unit of risk over similar time horizon. If you would invest 2,712 in Arvinas on August 29, 2024 and sell it today you would lose (264.00) from holding Arvinas or give up 9.73% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nurix Therapeutics vs. Arvinas
Performance |
| Timeline |
| Nurix Therapeutics |
| Arvinas |
Nurix Therapeutics and Arvinas Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nurix Therapeutics and Arvinas
The main advantage of trading using opposite Nurix Therapeutics and Arvinas positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nurix Therapeutics position performs unexpectedly, Arvinas can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arvinas will offset losses from the drop in Arvinas' long position.| Nurix Therapeutics vs. Foghorn Therapeutics | Nurix Therapeutics vs. Shattuck Labs | Nurix Therapeutics vs. Monte Rosa Therapeutics | Nurix Therapeutics vs. Kymera Therapeutics |
| Arvinas vs. C4 Therapeutics | Arvinas vs. Monte Rosa Therapeutics | Arvinas vs. Nurix Therapeutics | Arvinas vs. Foghorn Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |